Zimbabwe has turned down a significant American health deal valued at $367m (272 million pounds) over five years over the United States' request for sensitive data.
The decision became public following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official representative has since clarified that the United States was demanding access to genetic material for scientific study and commercial gain but was not willing to share the resulting advantages from future vaccines.
"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more talks to find a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the security of citizens' health data.
After returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the end products would be available to our population if a new disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining systems already set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent co-operation might be structured in a way that respects the independence and interests of both nations."
Health Experts Reaction
A leading public health body expressed it acknowledged the government's concerns, but suggested that talks should continue since much of the nation's HIV programmes were funded by external financing.
"Where technical issues exist, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group said.
This impasse highlights the ongoing tensions between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.